MSIMAker was this the piece you remembered .....Jun 12, 2015 - Narhex Life Sciences (ASX:NLS) has raised $4 million through its oversubscribed prospectus raising and will now proceed to complete its acquisition of ResApp Diagnostics Pty Ltd.
Ann: Becoming a substantial holder, page-4
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?